Epitope mapping of human aromatic l-amino acid decarboxylase

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 692-698

  Bratland, Eirik ^a,b   Wolff, Anette S Bøe ^b   Haavik, Jan ^b   Kämpe, Olle ^c   Sköldberg, Filip ^c   Perheentupa, Jaakko ^d   Bredholt, Geir ^a   Knappskog, Per M ^a   Husebye, Eystein S ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aromatic l amino acid decarboxylase; Autoantibodies; Autoimmune polyendocrine syndrome type I; Epitope mapping

Indexed keywords

ALANINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; AUTOANTIBODY; EPITOPE;

ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RARE DISEASE;

AROMATIC-L-AMINO-ACID DECARBOXYLASES; AUTOANTIBODIES; CARBOXY-LYASES; EPITOPE MAPPING; HUMANS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; POLYENDOCRINOPATHIES, AUTOIMMUNE; RECOMBINANT FUSION PROTEINS;

EID: 33845976293     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.080     Document Type: Article

References (26)

1. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, Nat. Genet. 17 (1997) 399-403.
2. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J., Lalioti M.D., Mullis P.E., Antonarakis S.E., Kawasaki K., Asakawa S., Ito F., and Shimizu N. Positional cloning of the APECED gene. Nat. Genet. 17 (1997) 393-398
3. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. (2006)
4. Soderbergh A., Myhre A.G., Ekwall O., Gebre-Medhin G., Hedstrand H., Landgren E., Miettinen A., Eskelin P., Halonen M., Tuomi T., Gustafsson J., Husebye E.S., Perheentupa J., Gylling M., Manns M.P., Rorsman F., Kampe O., and Nilsson T. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 89 (2004) 557-562
5. Soderbergh A., Rorsman F., Halonen M., Ekwall O., Bjorses P., Kampe O., and Husebye E.S. Autoantibodies against aromatic l-amino acid decarboxylase identifies a subgroup of patients with Addison's disease. J. Clin. Endocrinol. Metab. 85 (2000) 460-463
6. Christenson J.G., Dairman W., and Udenfriend S. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic l-amino acid decarboxylase-serotonin-dopamine-norepinephrine). Proc. Natl. Acad. Sci. USA 69 (1972) 343-347
7. Scherer L.J., McPherson J.D., Wasmuth J.J., and Marsh J.L. Human dopa decarboxylase: localization to human chromosome 7p11 and characterization of hepatic cDNAs. Genomics 13 (1992) 469-471
8. Zhu M.Y., and Juorio A.V. Aromatic l-amino acid decarboxylase: biological characterization and functional role. Gen. Pharmacol. 26 (1995) 681-696
9. Husebye E.S., Boe A.S., Rorsman F., Kampe O., Aakvaag A., Rygh T., Flatmark T., and Haavik J. Inhibition of aromatic l-amino acid decarboxylase activity by human autoantibodies. Clin. Exp. Immunol. 120 (2000) 420-423
10. Poupon A., Jebai F., Labesse G., Gros F., Thibault J., Mornon J.P., and Krieger M. Structure modelling and site-directed mutagenesis of the rat aromatic l-amino acid pyridoxal 5′-phosphate-dependent decarboxylase: a functional study. Proteins 37 (1999) 191-203
11. Ishii S., Mizuguchi H., Nishino J., Hayashi H., and Kagamiyama H. Functionally important residues of aromatic l-amino acid decarboxylase probed by sequence alignment and site-directed mutagenesis. J. Biochem. (Tokyo) 120 (1996) 369-376
12. Burkhard P., Dominici P., Borri-Voltattorni C., Jansonius J.N., and Malashkevich V.N. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase. Nat. Struct. Biol. 8 (2001) 963-967
13. Routsias J.G., Vlachoyiannopoulos P.G., and Tzioufas A.G. Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Crit. Rev. Clin. Lab. Sci. 43 (2006) 203-248
14. Skoldberg F., Rorsman F., Perheentupa J., Landin-Olsson M., Husebye E.S., Gustafsson J., and Kampe O. Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease. J. Clin. Endocrinol. Metab. 89 (2004) 1636-1640
15. Rorsman F., Husebye E.S., Winqvist O., Bjork E., Karlsson F.A., and Kampe O. Aromatic-l-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc. Natl. Acad. Sci. USA 92 (1995) 8626-8629
16. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
17. Husebye E.S., Gebre-Medhin G., Tuomi T., Perheentupa J., Landin-Olsson M., Gustafsson J., Rorsman F., and Kampe O. Autoantibodies against aromatic l-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 82 (1997) 147-150
18. Kim J., Namchuk M., Bugawan T., Fu Q., Jaffe M., Shi Y., Aanstoot H.J., Turck C.W., Erlich H., Lennon V., and Baekkeskov S. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 180 (1994) 595-606
19. Flatmark T., Jacobsen S.W., and Haavik J. Fluorometric detection of tryptophan, 5-hydroxytryptophan, and 5-hydroxytryptamine (serotonin) in high-performance liquid chromatography. Anal. Biochem. 107 (1980) 71-74
20. Dal Pra C., Chen S., Betterle C., Zanchetta R., McGrath V., Furmaniak J., and Rees Smith B. Autoantibodies to human tryptophan hydroxylase and aromatic l-amino acid decarboxylase. Eur. J. Endocrinol. 150 (2004) 313-321
21. Mackay I.R., and Rowley M.J. Autoimmune epitopes: autoepitopes. Autoimmun. Rev. 3 (2004) 487-492
22. Van Regenmortel M.H. Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines. J. Mol. Recognit. 19 (2006) 183-187
23. O'Connor K.H., Konigs C., Rowley M.J., Irving J.A., Wijeyewickrema L.C., Pustowka A., Dietrich U., and Mackay I.R. Requirement of multiple phage displayed peptide libraries for optimal mapping of a conformational antibody epitope on CCR5. J. Immunol. Methods 299 (2005) 21-35
24. Peterson P., and Krohn K.J. Mapping of B cell epitopes on steroid 17 alpha-hydroxylase, an autoantigen in autoimmune polyglandular syndrome type I. Clin. Exp. Immunol. 98 (1994) 104-109
25. Liiv I., Teesalu K., Peterson P., Clemente M.G., Perheentupa J., and Uibo R. Epitope mapping of cytochrome P450 cholesterol side-chain cleavage enzyme by sera from patients with autoimmune polyglandular syndrome type 1. Eur. J. Endocrinol. 146 (2002) 113-119
26. Volpato M., Prentice L., Chen S., Betterle C., Rees Smith B., and Furmaniak J. A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease. Clin. Exp. Immunol. 111 (1998) 422-428